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As the costs of health care increase, the ethical ramifications of the
system also grow. By this I mean that as we invest larger amounts of
resources in the delivery of health services (in both absolute dollars
expended as well as relative to other kinds of resource development),
the impact of the system on the lives of larger proportions of our
population becomes more pervasive and profound. This impact occurs
not only through obvious and direct ways such as delivering more
health care to underserved groups or providing new services to other
groups with consequent changes in health status,l but also there are
less obvious effects .
These indirect effects of our enlarging and increasingly expensive
system may have impacts at least as important on the lives of people.
These occur through the system's impact on the very conditions under
which people live. This then has ethical implications for those who, at
any level in the system, have a part in determining the size and shape
of health care in the nation or in any given community.
For example, we can roughly characterize our health care delivery
system in economic terms as inherently inflationary; that is, it is both
capital intensive (huge amounts of funds are required to develop and
equip its organizational emphasis on inpatient facilities) and energyintensive in (a) the development and maintenance of its technology as
well as (b) , its emphasis on specialized personnel, 80% of whom are
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attached to inpatient sites. 2 The indirect impact of this kind of system
on the lives of many communities and groups means at least the
following:
- To the extent that a specialized system can only be supported by
large and relatively affluent populations, it primarily locates in
urban and affluent communities, thereby contributing to the
urban-rural or central city-suburban income gaps, fostering the
decline of poor communities. 3
- Its costliness not only diminishes direct access to services by lower
income groups but also, because of predominant methods of financing, places a relatively greater burden on the income of those same
poorer groups through flat rate payments such as insurance premiums and social security taxes. 4
- The specialized emphasis among health personnel, increasingly credentialed through university degrees, has the effect of favoring the
entry, promotion, and income maintenance of those from privileged
households and of keeping those from poorer families in the lowerincome health occupations, with fewest opportunities for further
training or promotion. 5
- The 140 billion dollars used by the system each year means, in
effect, that those billions are not being used in alternative ways,
ways which may have potentially greater positive impacts on health. 6
In these broad ways then, the health care system as an economic
entity affects the communities, incomes, resources, the basic conditions under which large numbers of people live . To the extent that
certain groups, especially the lower-income, rural or ghetto communities, or elders, become or are maintained as deprived groups, the
system contributes to perpetuating their above-average burden of
disease, and makes them more vulnerable to future illness. This is the
basis of the ethical consequences - the impact on the chances for
health and life of community populations - flowing from the decisions which determine the size and character of our health care
system.
What follows is an attempt to focus these general concerns on a
specific area of decision-making within the delivery system, namely,
the development of screening programs. This is an area which is receiving increasing attention among community health personnel. It is a
service component which appears to be expanding on the assumption
that it is not characteristic of the system as a whole. In other words, it
is relatively not expensive, is readily deployable, is often relatively
simple and non-specialized, and is preventive in nature and thereby
health-promoting. I am following the generally accepted definition of
screening as "the presumptive identification of unrecognized disease
or defect through tests, examinations, or other readily applied measures carried out on apparently well individuals." 8 Thus, screening is a
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mode of secondary prevention in that it seeks to discover adverse
conditions in order to prevent their extension or sequelae.
The ethics of screening as a service per se has often been discussed
in its non-economic dimensions. These include such important issues
as whether to screen when treatment does not exist or is unavailable,
or whether to inform individuals of adverse findings when available
treatment may be ineffective. Rather clear-cut criteria have been
recently developed and widely discussed for guiding decisions on the
use of screening. 9
Ethical Aspects of Economics
Here our discussion will focus on the ethical aspects of the economics of screening programs. In order to examine this dimension some
basic questions must be addressed:
1. What is the efficacy of screening? That is, what is the usefulness
to the individual of the service rendered? Is the screening tool
able to detect disease or defect?
2. What is the effectiveness of screening? What health-promoting
impact is it actually having on a given population, and the related
prior question, is it reaching the appropriate population?
3. What is the efficiency of screening measured in cost-effectiveness
relative to other means of discovering illness, and/or measured in
cost-benefits , the dollar-value of savings in treatment and time
lost from consumers' daily activities?
Although the answers to these questions are only beginning to be
developed, there are available several efforts to summarize findings in
response to one or more of them, concerning either the efficacy,
effectiveness, HEW/Congress, or efficiency of screening programs. 10
The following discussion seeks to combine these interrelated aspects
of screening services in order to draw out the ethical implications
inherent in decisions to develop or expand these programs.
The most common screening techniques are of course the physical
examination and various kinds of biochemical or other tests. These
may be multiphasic or disease-specific. An analysis of what is known
about the efficacy of these techniques for a variety of age groups has
been made. 11
Some generalizations which may be drawn from the data are:
1. Routine physical examinations for children are not an efficient
means for discovering significant adverse conditions which are
not already known by the child's caretakers or which could not
have been detected by other means; this method is somewhat
more efficient for children from poor families who have no regular source of care (e.g., migrant workers' families).
2. Multiphasic screening produces a low yield of new findings in
general popUlations; it is somewhat more efficient among seNovember, 1977
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lected, high-risk groups such as lower income and black populations. The types of new diagnoses are relatively few and noncomplex , such as hypercholesterolemia and iron deficiency
anemia, especially among the poor. Although large proportions
of the tests show "abnormal" results, these are non-diagnostic
and their significance if any is not known. Such screening is
cost-effective only among client populations of 15,000 children
or 24,000 adults or more per year. 12 They have been shown to
alter morbidity only rarely, as among middle-aged men through
deferring death from cardiovascular disease and cancer.l 3

3. Routine disease-specific screening in infants and children,
whether by physical examination or laboratory tests, has yielded
low positive findings, often with a high proportion of false positives. Results are more efficient in selected high risk groups such
as families already known to have had children with birth anomalies. Congenital orthopedic problems are the most treatable. For
many others, such as the metabolic diseases, treatment is palliative. PKU, for which appropriate treatment is effective, is costbeneficial because of the life-long care required for its sequela of
mental retardation. However, as has been shown, the screening
procedure as done in the U.S. is not optimally-timed, thus missing
some children who are thereby lost to preventive treatment. 14
4. Screening for many growth and development variations in children has a very high risk of false positives among large proportions of children screened, without evidence that such findings
have any positive health effects. These measurements include
elevated blood pressure, anemia after age one, intestinal parasites,
and non-toxic blood lead levels; there is no evidence that medical
treatment, e.g., iron supplements, will alter the health and disease
patterns of these children. However, selective screening and intervention for dental, tubercular, and venereal diseases will alter the
course of illness.
5. The methods for mass, disease-specific screening in adults are
generally efficacious, i.e., they can detect underlying illness for
serious health problems, such as chronic lung disease, hypertension, and certain cancers. However, such methods are often not
effective for changing the course of illness among populations
because, as in the case of chronic lung disease or lung cancer,
treatment is palliative and does not apparently deter progression
of the disease. Or, as with hypertension, non-symptomatic patients
tend not to seek treatment or to be given treatment by their
physicians. 15 Or, again, there is question whether the findings
signify incipient illness at all, such as some bacterurias, anemias,
and hyperglycemia.
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There is also question as to what positive health effects are
possible from uterine and breast cancer screening except among
selected age groups; that is, at what point is screening costing
more than what is saved in lives and treatment costs? One study
showed that for the 23 women whose deaths from breast cancer
were deferred through early detection and treatment in a five
year screening program, the same effect could have been
obtained through a program for smoking prevention; for it is
likely that about 23 of the 31,000 screened women died of lung
cancer during that period. 16
Effectiveness of Screening Techniques
Clearly, efficacious screening techniques (i.e., those which can produce a high yield of true positives and low yield of false negatives)
become effective (i.e., make a measurable difference in the health of
populations) when they detect conditions which can be contained or
cured by available treatment. This implies that these screening processes will be more efficient in relation to funds expected when the
screening procedure is focused on selected, high-risk groups as compared with mass or otherwise haphazard programs in the general population.
However, the record of effectiveness for even efficacious screening
techniques has been limited. They have not succeeded in reaching the
appropriate groups even when the stated purpose was to focus on
selected populations-those groups more likely to be vulnerable to
particular illnesses or abnormalities because of familiar traits, age, sex,
or socio-economic deprivation. Large proportions of such populations
r~main untested. Table 1 illustrates the ineffectiveness of the segmented Medicaid approach to screening as well as the greater effectiveness that concerted follow-up efforts can have for cervical screening.
In large part, high-yielding, efficacious screening techniques are
limited in their effectiveness, even when properly focused on high-risk
groups, because they are generally segregated from follow-up and
treatment programs. The burden of obtaining appropriate confirmation and treatment falls on the consumer. This is particularly difficult
for those most likely to require treatment and least able to seek it due
to the press of day-to-day problems, as experienced by low-income
people. Their access to health services, even to programs specifically
intended to reach them, is made difficult because the system has not
effectively reached them as Table 2 illustrates.
Ambulatory care has reached only small proportions of low income
groups, those most vulnerable to illness. Thus, even accurate screening
and efficacious forms of treatment cannot be · effective in terms of
improving the outcomes in health for those populations. Too often, of
course, diagnosing and treating individuals' illnesses does little to
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improve the incidence and prevalence of symptoms which result from
poor living conditions (Table 2).
The problem of access is compounded by the ineffectiveness of
financing programs. Medicaid covers somewhat over half of lowincome families only, and pays no more than two-thirds of their
health care expenditures.
To reiterate the basic ethical question inherent in the economics of
screening programs : is the expenditure of resources, funds, personnel,
and agency capability justified when such programs cannot make a
measurable positive impact on the health of a given population? The
reasons why screening may not be capable of health-promoting
impacts include:
- the technology is not efficacious in specificity or sensitivity;
- the health problem is ill-defined, rare, self-limiting or untreatable;
- the delivery of the screening program is not directed to high-risk
populations or is not effective in reaching those groups;
- confirmation of and treatment for positive findings are not assured
through integration with effective services delivery and financing
programs.
To purposefully develop screening programs when they cannot
produce positive health impacts for one or more of these reasons has,
in tum, an indirect and negative impact on the health of the consumer
population in question. It means that the funds so expended, while
surely paying the costs of the health agency, are not being spent for
programs which do have potential for healthful results among the
population.
In other words, given limited resources, to what alternative uses can
screening funds be put when all of the criteria for a justifiable screening program cannot be met?
It is conceivable that with comparable resources, alternative programs in primary prevention might be developed or strengthened in
place of the effort at secondary prevention which screening programs
represent. For example, with due regard for the particular problems of
a given community, monies for child health might be used to provide a
truly effective immunization program, the efficacy of which is well
proven, but the effectiveness of which has been limited because of
inadequate outreach (Table 3). Concern over birth abnormalities
might alternatively be dealt with through efficacious technologies of
birth control techniques or food for poor women, both highly effective for healthful outcomes when effectively delivered (Tables 1 and
4). Again, whereas more high-lead blood levels are being found in lead
screening programs, the proportion of housing found with hazardous
lead paint has not changed. 17 Reducing such dangerous living conditions would be more cost-effective for the health of children in many
communities.
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When health care resources are used without known positive effects
on the health of community populations, they are not only wasted, but
also may have measurable , negative effects, directly, in absorbing consumers' time, causing concern and inconvenience, incurring out-ofpocket costs. And as importantly, the indirect impact is to deprive
them of potentially more-health-promoting uses of those resources.
The heightening of our awareness of this reality should imply that
program development requires thoughtful analysis before we dare rush
in with the somewhat faddish nature of new or revived service activities. The total picture needs viewing, with assessment made of the
relative impacts of alternative programs and strategies.
One way to do this is through working with the new health systems
agencies, with their developing areawide data-gathering capability.
Becoming acquainted with the growing literature on what "works" in
health services is also essential. Furthermore , developing alternative
and more healthful uses of community resources is further best done
in concert with c oncerned others, including human services and
environmental groups, and not least, community organizations and
representative consumers.
With these inputs, the size and shape of health care in given communities would be different from what we know now, and might
indeed impact more healthfully on people's lives.
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Table 1
The Effectiveness of Personal Health Services in Secondary Prevention:
Delivery of Screening Programs

Screening Programs

Effectiveness: % of Target
Population Reached

Early & Periodic Screening, Diagnosis &
Treatment (Medicaid), 1975 1

14.8 % screened
60.4 % of ill treated

Pap smears , annual teaching hospital clinic 2
Group practice with mailed reminders 2

4 8%

Follow-up for positive (cancerous) findings 3

88 %

25%
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Table 2
The Effectiveness and Efficiency of Personal Health Services
in Secondary Prevention: Delivery of Ambulatory Services
EFFICIENCY

EFFECTIVENESS
% of Target

Population
Reached

Cost/Effectiveness
Estimates

Health Outcomes

AMBULATOR Y CARE TO POOR a, 1, 2
Neighborhood
health centers
(314e & OEO)

2-25 %

Maternity and
infant projects

0.6-19

Children and

1.8-13

Some re duction in

hospital adm iss ion s
& eme rgency
outpatient visits,

Est. 10% drop in infant
deaths 1965-70. (20 deaths
prevented per 1000
births) ;6 little change in
prematurity rates.

youth projects

Free clinics 3

2.0-25

Migrant health
centers 4

?

FAMILY
PLANNING
SERVICES5

62
(rural : 48%)

$150-450/clinic session
($200/session)
Avg. $61,000/yr. project
81 % allocated to medical
services
29% of total to hospitals

No measurable
improvement.

;>

Free-standing
clinics,
General care clinics
Hospital-based
Private MD office

Est. 27 % drop in infant
deaths, 1965-70 6

32

$135,000/ project
$61 / pt. /y r. (1971)

$69 / ptJyr . (1971)
$55/pt./yr. (1971)
$24/ptJy r. (1971)
$96/ pt. / yr . .

( rural : 19% )

30
(rural:29%)

PREPAID GROUP PRACTICE 7
Physicians only
Nurse practitioner
& automated
screening

$131 / ptJy r.
$ 98 / ptJyr_

20xnew
entrants/y r.

PREPAID GROUP PRACTICES (1971)8

Low income
enrollees
All other
enrollees

0.05 % (of
poor)
6% (of U.S.
population)

Compared w /other

delivery models: 10
Death rate of elders
11 % lower ; infant
deaths 17-23%
lower.

ANNUAL
M.D.
Hospital adm .
Visits
(perl 000 pop. ) Cost/pt.
3.9-4 .0
60-iol
$75 ( low
(low inc.) (low inc . ) income)
4.2 (other 73-92
$47 (other
income)
(other inc.) income)
(U.S. avg.: 145 adms.
4.5 visits) (U.S. avg.)

ADULT AMBULATORY CARE 1969-72 9
Low-income

60-72 (% w /
symptoms)

Above-average

62-72 (% w/

Symptom prevalence
unchanged: higher for
poorer, lower for non-poor

income

sym ptoms)

CHILDHOOD AMBULATORY CARE 1969-72
Low-income

70-74 (% w/
symptoms)

Symptom prevalence
unchanged: roughly

Above-average

74-85 (% w/
symptoms)

similar fo r both groups ,
poor about the same as
non-poor.

income

a=poverty level to 200% above designated poverty leve l.
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Table 3
The Efficacy, Effectiveness, & Efficiency
of Personal Health Service for Primary Prevention of Disease:
Immunizations & Fluoride

1974
Polio
(3 doses +)1

63.1 60

DTP
(3 doses+)l

73.9 69.5 77.9 59.4 74.3

Measles 2

905

Rubella 3

68 .1 47

66.2

64.5 62.5 68 .5

1 life saved/
10,000 cases;
1 MR saved /
3,000 cases.

Net benefits:
(saved treatment,
long-term care,
2400 lives saved)
$l.3 billion.

59.8 6l.1 62.3

$3/patient;
$6 million
for all 2-yr.
olds.

$38.5 million ($1
in costs to 8 in
benefits) savings
on complications
of congenital
rubella in
newborn, care of
retarded, loss of
life-long
.
producti vity, etc.

Smallpox 4

*
**

$2.20 costs to $1
in benefits
(treatments
saved).

Vaccines also exist to prevent typhoid fever, yellow fever, epidemic typhus, Rocky
Mountain spotted fever, tuberculosis, meningitis , mumps, some influenza.
For a discussion of financial and geographic access to health care, see N . Milio, Care
of Health in Communities: Access for Outcasts (New York: Macmillan, 1975),
chaps. 3-5.
REFERENCES

1. House Subcommittee on Public Health and Environment, National Health Education & Disease Prevention Act, 1975, Nov., 1975 (Washington, D.C.: U.S. Government Printing Office, 1976).
Z. Schreier, H ., "On the Failure to Eradicate Measles," New England Journal of
Medicine 290 (April 4, 1974), pp. 803-4.
3. Schoenbaum, S., et. al., "Benefit-Cost Analysis of Rubella Vaccination Policy ,"
New England Journal of Medicine 294 (1976) pp. 306-10.
4. Sencer, D. , and Axnick, N., "Established Vaccines for Regular Programs: CostBenefit Analysis," Immunobio. Standardization 22 (1973), pp. 37-46.

November, 1977

357

Table 4
Improving Mothers' and Children's Health Relative Benefits
From Selective Approaches, 1960-1970 Data

APPROACHES

ESTIMATE OF BENEFITS

Improving women's nutrition,
quantity & quality , before
& during pregnancy.

Reduction in infant deaths by 50%.
R eduction in maternal deaths by 50%.
Improved child nutrition & decrease in
infections & deaths by 90%, age 1-4.

Lengthening and spac ing birth
intervals between age 20-34.

Reduction in infant deaths by 30%.
Improved child nutri t ion .

Dec reasing number of
pregnancies to 3 or fewer.

Reduction in infant deaths by 10%.
Improved child nutrition.

Stnpping smoking before and
during pregnancy.

Improved maternal health.
Addition of % to '/. lb . to infant,
avoid ing low birth we ight.

Pre nata l care to " high-risk"
women.

Less than 10% reduction in infant
d eaths.
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APPENDIX
Summary of Recommendations for Screening*
Criteria for Evaluation of Screening Programs
l.Screening must lead to an improvement in end -results (defined in terms of
mortality; physical , social and emotional function; pain; and satisfaction)
among those in whom early diagnosis is achieved or in the other members of
the community_
a_ The therapy for the condition must favorably alter its natural history, not
simply by advancing the point in time at which diagnosis occurs, but by
improving survival, function or both_ The modification of "risk factors" is
not sufficient evidence of effectiveness, nor is the fact that the proposed
therapy is "commonly accepted." Claims for therapeutic effectiveness must
withstand rigorous methodologic scrutiny, and experimental evidence, such
as controlled clinical trials, is a prerequisite. The measurement of survival and
other end-results must withstand epidemiologic and biostatistical scrutiny .
Disease should have a recognizable, latent (asymptomatic) stage. Screening
should be a continuous (not one-shot) process. Abnormality to be screened
should be precisely defined .
b. Available health services must be sufficient both to ensure diagnostic confirmation among those whose screening is positive and to provide long-term
care.
c. Compliance among asymptomatic patients in whom an early diagnosis has
been achieved must be at a level to be effective in altering the natural history
of the disease in question.
d. The long-te rm beneficial effects, in terms of end-results, must outweigh the
long-term detrimental effects of the therapeutic regimen utilized and the
"labelling" of an individual as "diseased " or "high risk."
2.The effectiveness of potential components of multiph asic screening should be
demonstrated individually prior to their combination.
3.If the benefits of screening accrue to the community at large rather than, or in
addition to, the individual ide ntified (e. g. , disease carriers, specific occupations), the community benefit claimed must withstand scientific scrutiny .
a. The appropriateness of the mix of screening tests to the target population
must be conside red, acknowledging that differences in the distribution of
two diseases may render the combination of their respective screening tests
inappropriate.
4.The cost-benefit and cost-effectiveness characteristics of mass screening and
long-term therapy must be known. This knowledge is considered essential in
developing an appropriate mix of diagnostic and therapeutic services in the face
of finite manpower and financial resources. Therefore, a mechanism for the
formal periodic weighing of costs against be nefits or effec tiveness should constitute a bas ic component of the ini tial screening activities.
5. The burden of disab ility for the condition in qu est ion (in terms of disease
frequency, distribution, severity, and alternative approaches to its detection
and control) must warrant action.
6.The cost , sensitivity, specificity, and acceptability of the screening test must be
known, and it should lend itself to the utili zatio n patterns of the target popula-

*Sourc e: National Conference on Preventive Medicine papers, June 7-9 , 1975,
Washington , D.C., NIH-ACPM.
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tion. Comparison should be mad e with previous preve nti on a nd treatment
m ethod s a nd other alt ern atives in order to d etermin e t h e relative efficacy and
cost· effectiveness of t h e proposed test.
7.Ideally , an estimate of the soc ial be ne fit of preventing, arresting, or c uring the
co ndition in question should be known . Difficulti es of wid espread impl ementation should b e studied. "Borderline findings should h ave a policy ."

Validation of Screening Test Methods

1. Simplicity . In many screening program s more than one test is used to detect one
disease, and in a multiphasic program the individu al will b e s ubj ected to a
number of tes ts within a sh o rt space of time. It is therefore esse nti al that th e
tests use d should be easy to administer and should be capable of use by p aram edical a nd other p erso nn el.
2.Acceptability. As screening is in most insta nces voluntary and a hi gh rate of
cooperation is necessary in an effic ie nt screening program , it is imp orta nt that
tests should be acceptable to th e s ubjects.
3.Accuracy. The test should give a tru e measurement of the att ribute under investigation.
4. Cost. The ex pense of sc reen ing should be considered in relation to the b enefits
resulting from the ea rly d etect ion of disease, i. e ., th e sever ity of the disease, t h e
advantages of treatm en t at an ea rly stage, an d the probability of cure.
5. (Prec ision (so m etimes called repeatability). Th e test sh o uld give co ns iste nt resu lts
in repeated trials.
6. Sensitivity. This m ay be d efined as the ability of th e tes t to give a positive
finding when the individual screened h as the disease or abnorm ality under
investigation.
7 . Sp ecifici ty. This m ay be defined as the abilit y of the test to give a negative
finding when the individual does not have the di sease or ab no rm ali ty under
investigatio n.
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